Ospedale San Luca
Lucca, Italy
6 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
Metastatic Non Small Cell Lung Cancer
Daiichi Sankyo740 enrolled243 locationsNCT05215340
Recruiting
Phase 3
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-small Cell Lung Cancer
Summit Therapeutics1,600 enrolled253 locationsNCT05899608
Recruiting
Phase 2Phase 3
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Non-small Cell Lung Cancer
BioNTech SE1,260 enrolled206 locationsNCT06712316
Recruiting
Phase 3
FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
Colorectal, Cancer
Gruppo Oncologico del Nord-Ovest238 enrolled24 locationsNCT06733038
Recruiting
Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis
Amyotrophic Lateral SclerosisMotor Neuron Disease
Istituto Auxologico Italiano200 enrolled3 locationsNCT06318598
Recruiting
Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases
Amyotrophic Lateral SclerosisMotor Neuron Disease
Istituto Auxologico Italiano200 enrolled1 locationNCT06318585
Recruiting
Phase 2Phase 3
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Kartos Therapeutics, Inc.268 enrolled83 locationsNCT05797831
Recruiting
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
Atrial FibrillationVentricular DysfunctionArrhythmias, Cardiac+22 more
University Hospital of Ferrara8,400 enrolled31 locationsNCT06324682